Tg Therapeutics (TGTX) Treasury Shares (2012 - 2026)
Tg Therapeutics (TGTX) posted quarterly Treasury Shares of $200.2 million for Q1 2026, up 3169.64% year-over-year from $6.1 million in Q1 2025, and up 99.73% quarter-over-quarter from $100.2 million in Q4 2025.
Tg Therapeutics (TGTX) Treasury Shares (2012 - 2026) Analysis & Trends
Tg Therapeutics' Treasury Shares history runs 15 years deep, the most recent figure standing at $200.2 million for Q1 2026.
- In Q1 2026, Treasury Shares rose 3169.64% year-over-year to $200.2 million; the TTM figure through Mar 2026 stood at $200.2 million (up 3169.64% YoY), while the FY2025 annual figure was $100.2 million, up 1013.71% from the prior year.
- Treasury Shares for Q1 2026 stood at $200.2 million, up from $100.2 million in the prior quarter.
- The five-year high for Treasury Shares was $12.9 million in Q1 2025, with the low at $41309.0 in Q3 2022.
- The 5-year median for Treasury Shares is $9.6 million (2023), against an average of $8.3 million.
- The sharpest annual moves came in 2022 and 2025: Treasury Shares changed 0.0% in 2022, then surged 4562.63% in 2025.
- Tg Therapeutics' Treasury Shares stood at $234000.0 in 2022, then changed by 0.0% to $234000.0 in 2023, then surged by 3746.15% to $9.0 million in 2024, then jumped by 1013.71% to $100.2 million in 2025, then surged by 99.73% to $200.2 million in 2026.
- Business Quant data shows TGTX's Treasury Shares at $200.2 million in Q1 2026, $100.2 million in Q4 2025, and $100.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 5.08 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.72 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 92,219.00 |
| 10 | Tg Therapeutics | 7.46 Bn | 6.78 Bn | 199.14 Mn | 11.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 200.23 Mn |
| Jun 30, 2026 | 11.22 Mn |
| Jun 30, 2026 | 200.23 Mn |
| Jun 30, 2026 | 11.22 Mn |
| Mar 31, 2026 | 200.20 Mn |
| Mar 31, 2026 | 200.20 Mn |
| Mar 31, 2026 | 8.35 Mn |
| Mar 31, 2026 | 8.35 Mn |
| Dec 31, 2025 | 100.23 Mn |
| Dec 31, 2025 | 3.54 Mn |
| Dec 31, 2025 | 3.54 Mn |
| Dec 31, 2025 | 100.23 Mn |
| Sep 30, 2025 | 12.53 Mn |
| Sep 30, 2025 | 100.20 Mn |
| Sep 30, 2025 | 100.20 Mn |
| Sep 30, 2025 | 12.53 Mn |
| Jun 30, 2025 | 6.88 Mn |
| Jun 30, 2025 | 9.49 Mn |
| Jun 30, 2025 | 9.49 Mn |
| Jun 30, 2025 | 6.88 Mn |